5th Annual Clinical Trials Summit 2014
Offering our customers the knowledge and connections for a profitable business
  • Amey Mane Wockhardt

  • Kumar Prabhash Tata Memorial Hospital

  • Sonal Vora Synergetik Learning Solutions

  • Deepti Sanghavi SIRO Clinpharm

  • Prashant Bodhe Medanta Duke Research Institute

  • Milind Antani Nishith Desai Associates

  • Sujeet Ojha Sanofi

  • Sujay Salvi SIRO Clinpharm

  • Saji Vijayan Lupin

  • Murtuza Bughediwala Stempeutics Research

  • Ashwani Pandita Glenmark

  • Godhuli Chatterjee Sanofi

  • Adam Kelch EMC Corporation (U.S.A)

  • Bhaswat Chakraborty Cadila Pharmaceuticals

  • Rajesh Nachankar Piramal Enterprises

  • Shabbir Rangwala INC

  • Ravisekhar Kasibhatta Lupin

  • Chirag Trivedi Sanofi India

  • Retesh Kumar Lambda

  • Manish Sharma Lambda

  • Sofi Joseph Pfizer

  • Richard Young Medidata (UK)

  • Ketan Lakdawala Medidata (UK)

10th & 11th June 2014, Kohinoor Continental Hotel, Mumbai, India

''A critical guide for successfully conducting clinical trials''

Sponsors & Exhibitors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Conference Info
  • Day One
  • Day Two
  • Speakers
  • Sponsors
  • Partners
  • Sponsorship Opportunity
  • Delegates
  • Pricing
  • Venue
  • Testimonials
  • Presentations
  • Gallery


Clinical trials and arguments associated with it have been in top news and headlines since past few months pursuant to the strict view taken by the apex court on the matter. The number of deaths in India resulting from clinical trials has increased to an unendurable figure of 2,868 during the period 2005-20121. If on the one hand this figure relating to number of deaths resulting from clinical trials is fearful, on the other hand the decline in the number of clinical trials and approval given for conducting such trials in last few months is equally shocking. Till April 2013, only 12 (twelve) clinical trials have been approved by the authority as compared to almost a three digit figure in last year2. This certainly raises a concern for the future of clinical trials in India- country which once was perceived as a fertile place for growth of clinical trials by most of the multi-national corporations. Currently estimated at USD 500 million, India's clinical research market was projected to more than double and cross USD one billion mark by 2016 driven by favourable factors like diverse and accessible population, availability of low cost and effective resources3. India has billion plus population and a home for various life threatening diseases. However, these disadvantages provide an opportunity for global medical practitioners and healthcare providers to look India as an effective destination for research and clinical studies. However, the current situation in India towards clinical trials is not very promising. Find out here in this summit on how we can bounce back especially overcoming the barriers and recent rules and guidelines from the government.

5th Annual clinical trials Summit 2014 will examine the current issues faced in clinical trials operations, addressing the risks, timeline and budget stipulations, while effectively tackling key challenges in overcoming trials agreement and site contract arbitration problems. This summit will discuss the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent &investigators management in order to improve & optimize the overall drug development effectiveness and ROI. Discover on how to implement and benefit from electronic data management & monitoring cost effectively. This conference will be shared by leading industrial practitioners across the region to promote practical discussions; especially on the know-how to manage needs, variability of different countries and institutions to enhance clinical operational excellence and vigilance.

Attendees will have the chance to learn, network and benchmark against the global top pharmas and local industry leaders on the best practices in talent, site, budget and performance management in clinical trials. The conference aims to provide a detailed analysis of what it takes to conduct clinical trials from a biopharmaceuticals and vaccines perspective in India and China and also addressing risk/benefit balance, anecdotal experiences of the multinational pharmaceutical industry in India and other parts of Asia, selection and role of CROs, logistics of operations, clinical trials management, government policies and pharmacovigilance.

5th Annual Clinical Trials Summit 2014 will provide you with the data that you need to recognize this complex and rapidly expanding sector. Knowing the future market, and what impacts will that has on future business opportunities? This is your opportunity to stay ahead by learning the latest trends and networking with the trendsetters.

It gives us immense pleasure in welcoming you to the 5th Annual Clinical Trials Summit 2014


  • Overview of Indian healthcare and clinical trial system towards 2015
  • Analysing the recent government rules and guidelines 
  • Discovering the new trends in global clinical trials and their role in India
  • Technologies that drive efficiencies in global clinical trials
  • Strategies to conduct successful interventional oncology trials in India
  • Updates on design of clinical drug
  • What are the expectations of regulatory authorities and what type of regulatory structure does India currently have?
  • Overcoming challenges faced in regulatory approval processes – obtaining drug/ clinical supplies import and export licenses in Asia
  • Regulatory review at the drugs controller general of India (DCGI) and central drugs standard control organization (CDSCO): science, quality, and speed
  • Effectively incorporating GCP & GCPs – Knowing what TO-DO and what NOT TO-DO
  • Adapting to India’s transformed regulatory landscapes to conduct clinical trials
  • Re-Thinking patient recruitment and patient experience 
  • Finding the ideal partner in outsourcing your logistics operations in India how to identify smart packaging solutions to balance quality and costs
  • Identifying the decision criteria for partnering with the right vendors in Asia
  • How to manage risks in clinical trials effectively and how to successfully incorporate risk sharing models in clinical trials
  • Finding the right clinical trial supply chain model to optimize the costs
  • Avoiding mistakes in data collection and ensuring profitability and to understand the long term operation strategies for managing clinical trials.
  • Understanding new e-clinical technologies to improve data quality and optimise clinical outcomes
  • Next generation of clinical trials – How big will the market be?


  • Pharmaceutical organisations
  • Generic pharmaceutical companies
  • Contract research organisations
  • Patient recruitment companies
  • Government - Department of health
  • Non-profit organisations/ Association
  • Consultants


CEO's, CTO's, CIO's, Presidents, Vice Presidents, Directors Heads & Managers of:

Clinical Research & Development, Clinical Research Services, Clinical Operations, Clinical Data Management, Clinical IT, Clinical Trials, Medical Affairs, Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study Design, Safety Surveillance, Subject Recruitment, E-Clinical Systems.


5th Annual Clinical Trials Summit 2014 -“A critical guide for successfully conducting clinical trials” Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors expand your knowledge of the latest business models and strategies in the high-level conference. Show casing the products of tomorrow in the co-located exhibition.

09:10 Coffee/Registration

10:00 - 10:30 Introduction

Ketan Lakdawala, Vice President, Professional Services, Medidata (UK)

10:30 - 11:15 What India can learn from the US and European markets: Streamlining clinical processes via technology

Richard Young, VP, EMEA, Medidata

11:15 - 12:00 An Indian Regulatory Update

Bhaswat Chakraborty, Senior VP & Chair, Research & Development Core Committee, Cadila Pharmaceuticals

12:15 - 12:30 Morning wrap-up

Ketan Lakdawala, Vice President, Professional Services, Medidata (UK)

12:30 - 1:30 Networking luncheon

1:30 - 2:15 Beyond EDC: Risk-based Monitoring

Shabbir Rangwala, VP of Clinical Operations, INC

2:15 - 3:00 Beyond EDC: Advances in Budgeting

Rajesh Nachankar, Senior Manager Clinical Research, Piramal Enterprises

3:00 - 3:15 Coffee

3:15 - 4:00 Panel Discussion with speakers from Cadila, Piramal, Medidata, and INC

4:00 - 4:15 Wrap-up

Ketan Lakdawala, Vice President, Professional Services, Medidata (UK)

08:30 – Coffee and registration

09:30 – Morning Chair’s opening remarks

Deepti Sanghavi, Senior Medical Writer-Medical Writing, SIRO Clinpharm


09:40 – Morning Keynote Address 1: Clinical Trials in Stem Cell Products

  • What are stem cells and types of stem cells
  • Current diseases under focus
  • Current regulations for stem cell research
  • Challenges in conduct of clinical trials with stem cells

Murtuza Bughediwala, Country Head, Malaysia, Stempeutics Research

10:10 – Morning Keynote Address 2: Moving from Paper to EDC

  • Why are Indian companies still using Paper?
  • What can we learn from other emerging markets?
  • What's next after the transition from paper to EDC

Richard Young, Vice President, EMEA, Medidata (UK)

10:40 – Morning Coffee/Tea & Networking


11:00 – Panel Discussion: Growing challenges & opportunities of clinical trial in India

  • Challenges of clinical trial product development during different phases
  • What are the current problems faced in today’s market and how to successfully overcome them in this highly competitive market?
  • Trial and project management issues
  • Recruitment and retention of patients
  • Improving the data quality with information technology and systems for trials
  • Systematic techniques for assisting recruitment for trials             


Deepti Sanghavi, Senior Medical Writer-Medical Writing, SIRO Clinpharm


Bhaswat Chakraborty, Senior VP & Chair, Research & Development Core Committee, Cadila Pharmaceuticals

Chirag Trivedi, Director & Head of Clinical Study Unit, Sanofi India

Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates

Ketan Lakdawala, Vice President, Professional Services, Medidata (UK)

11:40 – Navigating the complex path of clinical trials and ensuring persistent inspection readiness

Adam Kelch, Product Manager – Documentum for Life Sciences, EMC Corporation (U.S.A)

12:10 – Imaging End Points: T20 of clinical trials

Manish Sharma, AVP & Head, Medical Affairs & Imaging, Lambda

12:40 – Networking luncheon / Networking / Exhibition Visit

Afternoon Chair’s person

Prashant Bodhe, Director of Operations, Medanta Duke Research Institute


13:50  Panel Discussion: How to find the ideal partner in outsourcing your logistics operations in India

  • Deciding the parts and amount of your supply to outsource
  • Fixing service level agreements with your chosen vendor
  • Retaining enough control with effective feedback channels and data monitoring
  • Choosing a partner who can take necessary steps to rectify the situation when things go wrong


Prashant Bodhe, Director of Operations, Medanta Duke Research Institute


Ashwani Pandita, Head Quality Management & Training, Glenmark

Saji Vijayan, Head  Clinical Endpoint & Manager-Clinical Trials, Lupin

Sujay Salvi, Head, CTSM, SIRO Clinpharm

Sujeet Ojha, Senior Clinical Project Leader, Sanofi

14:40  Panel Discussion  Relationships: Sponsor – Site – CRO & Patients

  • How to source the right partners, sponsor, vendor partnerships and avoid mistakes in selecting an outsourcing partner to conduct clinical trials
  • Patient-centric approach to clinical trials
  • How will indian CRO's analyse the current opportunities to invest in early stages of drug discovery or biotechnology start-ups?
  • In what way can the realistic expectations, clear communications, shared understandings, practical policies, and efficient problem resolution methods be developed between sponsors, sites and CROs
  • The current perspectives on the future of outsourcing in Asia
  • Advantages of a collaborative clinical trial alliance for greater efficiency and cost reduction


Prashant Bodhe, Director of Operations, Medanta Duke Research Institute


Ravisekhar Kasibhatta, Vice President – Clinical Research, Lupin

Godhuli Chatterjee, Senior Medical Advisor & Clinical Safety Officer, Sanofi

Sonal Vora, Founder & Director, Synergetik Learning Solutions

Kumar Prabhash, Prof, Medical Oncology, Tata Memorial Hospital

Retesh Kumar, Associate Vice President - Global Pharmacovigilance, Lambda

15:20 – Afternoon Coffee/Tea & Networking

15:40 – Potential of Phase II Trials in Drug Development

  • Unmet medical needs: when a well designed Phase II study is adequate for approval
  • Design and control issues in PoC Phase II studies: Best Phase II designs
  • Decision to proceed to Phase III or terminate based on Phase II results
  • End point selection
  • ITT and per protocol analyses
  • Operational challenges

Bhaswat Chakraborty, Senior VP & Chair, Research & Development Core Committee, Cadila Pharmaceuticals


16:10 – Panel Discussion: Adapting to India’s transformed regulatory landscapes to conduct clinical trials

  • Determining the changing dynamics of clinical trials regulatory requirements in India
  • Analyzing the regulatory scenario on clinical trials in India
  • Establishing an exact form and volume of data required to ensure a timely approval process
  • Developing effective strategies to comply to the regulations to gain quick market authorization
  • Overcoming challenges to create an effective clinical trial design in India


Milind Antani, Head-Pharma LifeSciences group, Nishith Desai Associates


Sofi Joseph, Head – Regulatory Operations, Pfizer

Amey Mane, DGM-Medical Affairs, Wockhardt

Murtuza Bughediwala, Country Head, Malaysia, Stempeutics Research

16:50 – Chairperson’s closing remarks and end of conference

Prashant Bodhe, Director of Operations, Medanta Duke Research Institute

17:00 – 18:00  Networking Drinks Session

Amey Mane

DGM - Medical Affairs


Kumar Prabhash

Prof, Medical Oncology

Tata Memorial Hospital

Sonal Vora

Founder & Director

Synergetik Learning Solutions

Deepti Sanghavi

Senior Medical Writer-Medical Writing

SIRO Clinpharm

Prashant Bodhe

Director of Operations

Medanta Duke Research Institute

Milind Antani

Head-Pharma LifeSciences group

Nishith Desai Associates

Sujeet Ojha

Senior Clinical Project Leader


Sujay Salvi

Head, CTSM

SIRO Clinpharm

Saji Vijayan

Head - Clinical Endpoint & Manager - Clinical Trials


Murtuza Bughediwala

Country Head, Malaysia

Stempeutics Research

Ashwani Pandita

Head Quality Management & Training


Godhuli Chatterjee

Senior Medical Advisor & Clinical Safety Officer


Adam Kelch

Product Manager Documentum for Life Sciences

EMC Corporation (U.S.A)

Bhaswat Chakraborty

Senior VP & Chair, Research & Development Core Committee

Cadila Pharmaceuticals

Rajesh Nachankar

Senior Manager Clinical Research

Piramal Enterprises

Shabbir Rangwala

VP of Clinical Operations


Ravisekhar Kasibhatta

Vice President Clinical Research


Chirag Trivedi

Director & Head of Clinical Study Unit

Sanofi India

Retesh Kumar

Associate Vice President - Global Pharmacovigilance


Manish Sharma

AVP & Head, Medical Affairs & Imaging


Sofi Joseph

Head Regulatory Operations


Richard Young

Vice President, EMEA

Medidata (UK)

Ketan Lakdawala

Vice President, Professional Services

Medidata (UK)


Virtue Insight

Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.



We provide innovative clinical development solutions that safely and efficiently improve quality of life. We provide our customers with a competitive advantage by facilitating operational excellence in their clinical research processes:

  • Eliminating redundant and error-prone processes
  • Fostering collaboration via dynamic information flow between traditional trial   design, planning, execution and analysis silos
  • Increasing study execution agility through insightful decision-making
  • Maximizing value to sites and sponsors by supporting a best-in-class solution approach

Salzer Technologies

We are specialists in systems-integration around Content Management and collaboration, Compliance and risk management, Bioinformatics and analytics for Life Sciences industry. We are the preferred partner of EMC.

Life Sciences Industry Solutions:
eTMF: electronic Trial Master File
Q&M: Quality & Manufacturing

Salzer Technologies delivers value-added, cost-effective business and technology enabled solutions and services of the highest quality to customers to make a remarkable difference in the corporate world, triggering and adding economic value with a unique insight in the client’s business.



Lambda Therapeutic Research is a leading full service CRO in the Clinical research domain. Headquartered in Ahmedabad (India), its global footprint encompasses strategically located offices in Mumbai (India), Poland (Europe), London (UK), USA and Canada (North America)

Since its inception in 1999, Lambda has grown both organically and inorganically and has gone on to establish a truly global presence. Its prime locations world-wide ensure ground level support in addition to easy access to a competent blend of human expertise and state-of-the-art infrastructure in the most efficient yet cost effective way. Lambda has BA/BE and Phase 1 facilities in India, Poland and Canada helmed by dedicated and experienced teams. It has recently commissioned Bio Analytical and Clinical Laboratory facilities and established a Business Development office in London (UK).

Lambda’s global infrastructure comprises of an impressive tally of 600+ clinical beds dedicated to Phase I clinical studies and bioequivalence studies. It has conducted more than 4800 Phase l, bioavailability / bioequivalence and/or drug-interaction studies of over 300 different chemical entities. Lambda’s database of adult male and female volunteers now exceeds 100,000 on a global level.

Lambda has extensive experience of conducting clinical studies in subjects of diverse sub groups, such as healthy and post menopausal female populations in addition to healthy male subject populations. It has conducted studies for its clients, for several regulatory agencies including ANVISA-Brazil, EMEA (Germany, Netherlands, France and other EU member state), UK-MHRA, TGA-Australia, AGES, TPS-Canada, USFDA and WHO. Since its inception, Lambda’s world-class facilities have consistently and successfully passed regulatory inspections by regulatory agencies such as DCGI, USFDA, ANVISA-Brazil, MHRA, Health Canada, AFSSAPS, Turkish-MoH and WHO.



We are an emerging company with an aim of providing business solutions across Web Designing, Web Application Development, Software Development, Multimedia Services and Mobile Solutions.

We work on a diverse product line of services which are developed compatible for various frameworks, providing a complete project design and development using our high standard technical team. We believe not only to produce exceptional in-house application we focus also on enhancing the commercial values for the customer end user applications. We extend our power of imagination across various verticals of IT services making the customer highly satisfied by providing an individual attention to each and every customer irrespective of the high, medium & large scale of organization.

We also provide value added service that includes the service apart from our core standard service, we give a valuable testing unit and a complete support from our back end .We would like to hear from the customer periodically and we monitor our growth based on the customer quotes & comments and work hard on fixing those reported problems and include the fixes in our library based on the system designs and code compatible requirements.

We generally release our product to our customer in a three phases, initially on the first phase with the beta version to make the customer to have a look in to our product whether their requirement is achieved. On the next phase we roll out our RC (Release Candidate) version of our product with all the fixes and features completely include, then on the third phase we deliver our final release on the promised date of delivery. On all these phase we completely integrate our technical and management resources with the customer dedicatedly making us much flexible to serve the customer to their maximum All these development life cycle has been maintained in a limited set of budget making the customer highly satisfied.



We provide innovative clinical development solutions that safely and efficiently improve quality of life. We provide our customers with a competitive advantage by facilitating operational excellence in their clinical research processes:

  • Eliminating redundant and error-prone processes
  • Fostering collaboration via dynamic information flow between traditional trial   design, planning, execution and analysis silos
  • Increasing study execution agility through insightful decision-making
  • Maximizing value to sites and sponsors by supporting a best-in-class solution approach

KAP Computer Solutions Pvt. Ltd

For Business Enterprises, KAP Computer Solutions(KAPSYSTEM) is one of the fastest growing Bulk SMS Company in India when it comes to Bulk SMS  Solution which offers Promotional and Transactional Bulk SMS Services along with HTTP API, Integration Kit, Source Code on Different Technologies to integrate on your either Application Specific(CRM, ERP, SAP, Supply Chain Management, etc…) or Technology Specific(Java, Dot Net, Php, etc…). At present, we cater over 8000+ customers across industries in India varying from major Banks, IT Companies, Corporates, Fortune 500 Companies, etc. Our messaging routes are being used by major Enterprises, varying from Wipro Technologies, Aditya Birla, Mahindra Holidays, Swaraj Mahindra, DLF, DHFL, E & Y Financial Services, IndiaFirst Insurance, Canara Bank, INGVysya Bank, HDFC Life, CGI, Bharat Petroleum, Dr. Batra's, Bhima Jewellery and more.


Crescent Scientific

We are in the field of Analytical-Scientific Instrumentation with full service operations in all major cities of India (www.cspl.in). We offer products and services associated with categories like Chromatography, Dissolution, Extraction, Sample preparation and evaporation.

We have over the past decade and more been very successful in providing our customers with quality products and technology backed by prompt service in the process also helping our principals to successfully establish their brands in India. We hope to continue bringing newer technology and products for the benefit of our customers and in helping them achieve their goals in the ever-changing field of science, research and development.

The Rapid 50 EC System is an evaporation (E) and concentration (C) system which can handle the evaporation of 50 samples simultaneously. Rapid 50 uses interchangeable rack which can accommodate volumes upto 30 ml of various volumes. Rapid 50 employs a microprocessor to control the time/temp and gas functions. Additionally Rapid 50 can be hooked to a printer for reporting and validation.

Dependable Product Performance

  • Developed in-hours by our R&D professionals with decade of experience in designing analytical equipment
  • Rigorously tested to deliver reliable quality
  • Rapid 50 components sourced from reliable sources worldwide

Dependable Quality

  • European Certification
  • Complies with highly stringent European standards for health quality and environment protection
  • 2years of performance warranty

Dependable Unique Features

  • Rapid 50 can be attached to a printer
  • Enable ease of recording and retriev


Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location.  Each event includes detailed information, like, description, dates, location, map, prices, link to the official event's  website and more...

If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you'll find it in Clocate.com

Lex Witness

LEX WITNESS – India’s 1st Magazine on Legal & Corporate Affairs

LEX WITNESS vows to be a high quality monthly magazine with the powers of fresh and original content that would deal exclusively with subjects pertaining to legality. Country's top notch practitioners and experts are being invited to contribute in WITNESS with what we feel is relevant to all stakeholders in this profession, aiming at brainstorming between the legal luminaries and hence bettering this practice in all its aspects.

Physis Learing Academy


BusinessVibes is a global B2B networking site which is home to 600+ associations and 200,000+ companies in 92 countries worldwide.We use a social networking model to promote business partnerships between companies in the US, Europe, India, China, and other major economies.


pharmaphorum is the primary facilitator of thought leadership and innovation within pharma. We support the next generation of pharmaceutical industry leaders through producing, curating and publishing media that will help pharma embrace the challenges of being a healthcare solutions provider in the 21st century.

Our services include:

  • Publication of interesting new written, audio and video content addressing critical pharma issues from around the world.
  • Showcasing key service providers who can work with pharma executives to forge the business models of the future.
  • Curation of global news, industry events and job opportunities within pharma.
  • Production of written, audio and video content for publication on pharmaphorum or client channels.
  • Advice and support on the use of social media within pharma to effectively connect companies, improve PR and share innovation.

Going to meet

Partnering with Virtue Insight means more than making the right contacts. It means being an insider. It means being connected to the right people with the right level of influence, and it means you are allied with a globally respected organization and leaders in the industry.?

Sponsorship, exhibiting and advertising packages are designed to provide a solid platform to help you stand out and make an impact. Our programs allow you to achieve your marketing goals and deliver a maximum return on your investment. We have developed convenient and customizable packages to help your organization meet its objectives and reach your target market.

Why Sponsor / Exhibit:

PROFIT: To Maximize
MARKET SHARE: Defending and Increasing Market Share
COMPETITION: To attach and defend against competition


  • Generating sales leads
  • Build brand image
  • Maintaining customer relations
  • Consolidating business relationships
  • Accessing new and emerging markets
  • Obtaining technical knowledge
  • Leverages the events extensive marketing campaign to add value to your organisations marketing strategy and budget leading up to the event
  • Live product demonstration to test market responses
  • Facilitating quick market penetration
  • Reach important targeted commercial prospects face to face in a social, relaxed environment. The ideal platform to build strong business friendships Strengthen your market position

Our conferences offer not only a unique combination of benefits (as listed above) to enable the sponsor/exhibitor to communicate the message but also a major opportunity that other forms of selling or media cannot provide.

Contact Us Today

Email - sponsor.uk@virtueinsight.com
Tel: +44-2036120886

Email - sponsor@virtueinsight.com
Tel: +91 44 64536444

Our highly researched conference agenda delivers all the latest information and our world-class speakers attract delegates from around the world to attend. We aim for our attendees to be equipped with knowledge of latest developments and enable them to network with the industry key personnel.

What is the format of our conference programme?
The conference programme consists of world-class keynote addresses, case study presentations and panel discussions.

What are the benefits of attending?

  • Meet your peers in an interactive, discussion-based format designed to maximize knowledge transfer and networking
  • Enjoy our informal networking at drinks and lunch
  • Meet the leading solution providers in the market to forge partnerships and discover solutions
  • Receive electronic versions of the conference documentation for use of reference post-event.
  • Get ideas for?training topics?that you might want to present as professional development sessions to others in your workplace.
  • Observe speakers from the perspective of seeing what works really well so you can learn new public speaking techniques and strategies that you can apply when doing your own presentations.
  • Learn what not to do in presentations if you end up sitting through any sessions that fail to be engaging or informative.
  • Delegates also benefit from discounted rates onfuture event attendance

For more information or to register at the event please contact us TODAY:

Contact Us Today

Email - delegate.uk@virtueinsight.com
Tel: +44-2036120886

Email - delegate@virtueinsight.com
Tel: +91 44 64536444


  • Topic was very good huge on current seminar
  • Location is very good to Aelequase
  • Speaking was good to deliver current situation
  • Very on panel discussion and due and Answer session
Rajesh Telawade
Sr. CRA, Lambda Therapeutic Research

Many presentations covered were eye openers and being from a typical IT Service provider company, the conference really added value in terms of clarifying the business processer and challenges of Pharma industrials

Souvik Bit
Associate Business Manager, HCL Technologies Ltd

This conference was informative. There was good exchange of information. It provided current and actual seminar in india regarding Clinical Trials would like to attend this conference in future.

Satish A Gaikwad
Clinical Research Associate, Lambda Therapeutic Research

Well Organized

Team Leader, Lotus Labs

The sessions was informative on products and the discussions was fantastic. It has given a better idea on where the industry is heading. To start a new era of clinical trials, this seems to be a promising start for the industry. The second innings for the clinical trials seems promising technically as well as operationally

Rajesh Krishnan
Senior Business Analyst, HCL Technologies
DOWNLOAD 5th Pharma Anti Counterfeiting 2016_Final List of Attendees
DOWNLOAD Murtuza Bughediwala, Stempeutics Research - Conference
DOWNLOAD Shabbir Rangwala, INC - Workshop
DOWNLOAD Richard Young, Medidata (UK) - Workshop
DOWNLOAD Rajesh Nachankar, Piramal Enterprises - Workshop
DOWNLOAD Bhaswat Chakraborty, Cadila Pharmaceuticals - Workshop
DOWNLOAD Richard Young, Medidata (UK) - Conference
DOWNLOAD Manish Sharma, Lambda - Conference
DOWNLOAD Deepti Sanghavi, SIRO Clinpharm - Conference
DOWNLOAD Bhaswat Chakraborty, Cadila Pharmaceuticals - Conference
DOWNLOAD Adam Kelch, EMC Corporation (U.S.A) - Conference
You have been registered successfully!
Enter Password
Submit Close